×
For best experience we recommend to activate Javascript in your browser.
AGBL2 antibody (AA 92-126)
The Rabbit Polyclonal anti-AGBL2 antibody (Clone RB47039) (ABIN6243589) specifically detects AGBL2 in WB.
The antibody is reactive with Zebrafish (Danio rerio) samples.
Catalog No. ABIN6243589
$383.35
$451.00
save $67.65 (-15 %)
Plus shipping costs $50.00
80 μL ABIN6579082
400 μL ABIN6243589
80 μL ABIN6579082
400 μL ABIN6243589
Delivery in 10 to 11 Business Days
Quick Overview for AGBL2 antibody (AA 92-126) (ABIN6243589)
Target
See all AGBL2 Antibodies
AGBL2
(ATP/GTP Binding Protein-Like 2 (AGBL2))
Reactivity
All reactivities for AGBL2 antibodies
Zebrafish (Danio rerio)
Host
All hosts for AGBL2 antibodies
Rabbit
Clonality
All clonalities for AGBL2 antibodies
Polyclonal
Conjugate
All conjugates for AGBL2 antibodies
This AGBL2 antibody is un-conjugated
Application
All applications for AGBL2 antibodies
Western Blotting (WB)
Clone
RB47039
Product Details anti-AGBL2 Antibody
(hide)
Binding Specificity
All epitopes for AGBL2 antibodies
AA 92-126
Purification
This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This (DANRE) zte25 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 92-126 amino acids of DANRE zte25.
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
WB: 1:1000
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Expiry Date
6 months
Target Details for AGBL2
(hide)
Target
AGBL2
(ATP/GTP Binding Protein-Like 2 (AGBL2))
Alternative Name
zte25
Background
Metallocarboxypeptidase involved in the detyrosination of alpha-tubulin C-terminus (By similarity).
Molecular Weight
82236
UniProt
A6H8T7
Recently viewed
(hide)
Chat with us , powered by LiveChat